Ribavirin Dosage in Patients With HCV Genotypes 2 and 3 Who Completed Short Therapy With Peg-Interferon Α-2b and Ribavirin
Alimentary Pharmacology and Therapeutics - United Kingdom
doi 10.1111/j.1365-2036.2010.04290.x
Full Text
Open PDFAbstract
Available in full text
Date
March 8, 2010
Authors
Publisher
Wiley